| 116 | 0 | 61 |
| 下载次数 | 被引频次 | 阅读次数 |
目的 探讨血清相关炎症标志物和肺功能指标在儿童肺炎支原体肺炎(MPP)中的改变及其对病情严重程度的预测价值。方法 选取2023年1月1日至2023年12月31日因MP感染确诊为MPP患儿174例为研究对象进行回顾性分析。根据病情的严重程度分为,轻症MPP组(n=85例),重症MPP组(n=89例)。比较两组患儿实验室指标、肺功能和影像学相关指标间的差异,采用多因素Logistic回归分析重症MPP患儿的危险因素,采用受试者工作特征曲线(ROC)分析各指标对重症MPP的早期预测价值。结果 两组患儿在热程、发热程度、肺部体征、阿奇霉素使用时间、影像学特征、病变范围、住院时间的差异有统计学意义(P<0.05)。两组患儿入院时重症MPP组血清炎症指标WBC、NEUT、ESR、LDH、CRP和D-dimer均高于轻症MPP组(P<0.05);重症MPP组CD4+/CD8+低于轻症MPP组(P<0.05)。重症MPP组患儿肺功能相关指标均低于轻症MPP组,差异有统计学意义(P<0.05)。多因素Logistic回归分析结果显示,高水平的ESR(P=0.013,OR=1.293,95%CI=1.057~1.582)、CRP(P=0.014,OR=1.173,95%CI=1.033~1.326)、LDH(P=0.046,OR=1.237,95%CI=1.140~1.689)、D-dimer(P=0.038,OR=1.569,95%CI=1.346~2.387)和低水平的FEV1/FVC%(P=0.044,OR=0.704,95%CI=0.501~0.990)是重症MPP的独立危险因素。各指标联合检测对预测重症MPP的AUC显著高于单一检测指标(Z=1.267、2.102、1.380、1.831、2.026,P<0.05)。结论 血清相关炎症指标ESR、CRP、LDH、D-dimer升高,FEV1/FVC%降低是重症MPP的独立危险因素,联合检测对MPP病情严重程度具有较高的预测价值。
Abstract:Objective To investigate the changes in serum inflammatory markers and pulmonary function indicators in children with Mycoplasma pneumoniae pneumonia(MPP) and assessed their predictive value for disease severity.Methods 174 children diagnosed with MPP due to MP infection from January 1,2023 to December 31,2023 were selected as the study objects for retrospective analysis.According to the severity of the disease, they were divided into mild MPP group(n=85 cases) and severe MPP group(n=89 cases).The differences of laboratory indicators, lung function and imaging related indicators were compared between the two groups.The risk factors of children with severe MPP were analyzed by multivariate Logistic regression, and the early predictive value of each indicator for severe MPP was analyzed by receiver operating characteristic curve(ROC).Results There were significant differences in heat course, fever degree, pulmonary signs, azithromycin use time, imaging features, lesion scope and hospital stay between the two groups(P<0.05).The serum inflammatory indexes WBC,NEUT,ESR,LDH,CRP and D-dimer in severe MPP group were higher than those in mild MPP group at admission(P<0.05).CD4+/CD8+ in severe MPP group was lower than that in mild MPP group(P<0.05).The relevant indexes of lung function in the severe MPP group were lower than those in the mild MPP group, and the difference was significant(P<0.05).Multivariate Logistic regression analysis showed that high levels of ESR(P=0.013,OR=1.293,95%CI=1.057~1.582)、CRP(P=0.014,OR=1.173,95%CI=1.033~1.326)、LDH(P=0.046,OR=1.237,95%CI=1.140~1.689)、D-dimer(P=0.038,OR=1.569,95%CI=1.346~2.387) and low level of FEV1/FVC%(P=0.044,OR=0.704,95%CI=0.501~0.990) was an independent risk factor for severe MPP.The AUC for predicting severe MPP was significantly higher with combined detection than with single detection(Z=1.267,2.102,1.380,1.831,2.026,P<0.05).Conclusion Serum related inflammatory indicators ESR,CRP,LDH,D-dimer increased, FEV1/FVC% decreased, which is an independent risk factor for severe MPP,and the combined detection has high predictive value.
[1]OJUAWO O,OJUAWO A,ALADESANMI A,et al.Childhood pneumonia diagnostics:a narrative review[J].Expert Rev Respir Med,2022,16(7):775-785.
[2]LI Z J,ZHANG H Y,REN L L,et al.Etiological and epidemiological features of acute respiratory infections in China[J].Nat Commun,2021,12(1):5026.
[3]赵顺英,钱素云,陈志敏,等.儿童肺炎支原体肺炎诊疗指南(2023年版)[J].新发传染病电子杂志,2024,9(1):73-79.ZHAO S Y,QIAN S Y,CHEN Z M,et al.Guidelines for diagnosis and treatment of mycoplasma pneumonia in children(2023 Edition)[J].JRID,2024,9(1):73-79.
[4]孙国磊,王一民.肺炎支原体感染诊断方法的研究进展[J].医学综述,2021,27(10):1961-1965.SUN G L,WANG Y M.Research progress on diagnostic methods for mycoplasma pneumoniae infection[J].Medical Recapitulate,2021,27(10):1961-1965.
[5]喻文清,陈欣,王浩入,等.重症肺炎支原体肺炎的影像学研究进展[J].中国中西医结合影像学杂志,2022,20(5):494-496,500.YU W Q,CHEN X,WANG H R,et al.Progress in imaging research of severe mycoplasma pneumonia[J].CIJ-ITWM,2022,20(5):494-496,500.
[6]殷勇,陈健德.儿童大环内酯类耐药肺炎支原体肺炎诊疗理念与实践[J].临床儿科杂志,2024,42(3):177-181.YIN Y,CHEN J D.Diagnosis and practice of macrolide resistant mycoplasma pneumonia in children[J].KLIN PADIATR,2024,42(3):177-181.
[7]ZHOU Y,SHAN Y,CUI Y,et al.Characteristics and outcome of severe mycoplasma pneumoniae pneumonia admitted to picu in shanghai:a retrospective cohort study[J].Crit Care Explor,2021,3(3):e366.
[8]LEE K L,LEE C M,YANG T L,et al.Severe mycoplasma pneumoniae pneumonia requiring intensive care in children,2010-2019[J].J Formos Med Assoc,2021,120(1 Pt 1):281-291.
[9]LAGUNAS-RANGEL FA.Neutrophil-to-lymphocyte ratio and lymphocyte-to-C-reactive protein ratio in patients with severe coronavirus disease 2019(COVID-19):a meta-analysis[J].J Med Virol,2020,92(10):1733-1734.
[10]何小珊,侯鸿标,江玉婷,等.CT联合MP-DNA及血清CRP、PCT检测在小儿重症支原体肺炎中的诊断及评估中的应用分析[J].药物生物技术,2024,31(6):683-687.HE X S,HOU H B,JIANG Y T,et al.Application of CT combined with MP-DNA,serum CRP and PCT in the diagnosis and evaluation of severe mycoplasma pneumoniae pneumonia in children[J].Pharmaceutical Biotechnology,2024,31(6):683-687.
[11]刘峰.肺炎支原体肺炎与预后相关的临床指标[J].临床儿科杂志,2022,40(4):247-251.LIU F.Clinical indicators related to prognosis of mycoplasma pneumoniae pneumonia[J].KLIN PADIATR,2022,40(4):247-251.
[12]LEE E,LEE Y Y.Predictive factors of the responses to treatment of mycoplasma pneumoniae pneumonia[J].J Clin Med,2021,10(6):1154.
[13]马瑞,裴亮.儿童难治性肺炎支原体肺炎早期临床预测因素[J].中国医科大学学报,2023,52(11):1015-1017.MA R,PEI L.Early clinical predictive factors for refractory mycoplasma pneumoniae pneumonia in children[J].J China Med Univ,2023,52(11):1015-1017.
[14]SARTORI L F,ZHU Y,GRIJALVA C G,et al.Pneumonia severity in children:utility of procalcitonin in risk stratification[J].Hosp Pediatr,2021,11(3):215-222.
[15]翁翠琦,陈玉梅,蒋蕾,等.小儿肺炎支原体肺炎血清CRP、PCT、ESR水平与病情严重程度的关系[J].中华医院感染学杂志,2022,32(8):1220-1223.WENG C Q,CHEN Y M,JIANG L,et al.The relationship between serum CRP,PCT,ESR levels and severity of Mycoplasma pneumoniae pneumonia in children[J].Chin J Nosocomiol,2022,32(8):1220-1223.
[16]HUANG X,LI D,LIU F,et al.Clinical significance of D-dimer levels in refractory Mycoplasma pneumoniae pneumonia[J].BMC Infect Dis,2021,21(1):14.
[17]朱颖.降钙素原、D-二聚体以及NT-proBNP在重症肺炎患者病情及预后评估中的应用[J].罕少疾病杂志,2024,31(2):44-46.ZHU Y.The application of procalcitonin,D-dimer,and NT-proBNP in the evaluation of the condition and prognosis of patients with severe pneumonia[J].JRUD,2024,31(2):44-46.
[18]张立霞,朱峰,李传景,等.重症肺炎支原体肺炎患儿CRP、LDH等实验室指标的预警价值及支气管镜下特点[J].中华全科医学,2024,22(7):1098-1101.ZHANG L X,ZHU F,LI C J,et al.The warning value and bronchoscopic characteristics of laboratory indicators such as CRP and LDH in children with severe mycoplasma pneumoniae pneumonia[J].Chin J General Practice,2024,22(7):1098-1101.
[19]郑晓惠,黎燕妹.D-二聚体、NLR、PLR、CRP、FEV1/FVC水平与慢性阻塞性肺疾病严重程度的相关性研究[J].临床误诊误治,2024,37(14):48-54.ZHENG X H,LI Y M.Correlation between D-dimer,NLR,PLR,CRP,FEV1/FVC Levels and the severity of chronic obstructive pulmonary disease[J].Clinical Misdiagnosis and Mistreatment,2024,37(14):48-54.
基本信息:
中图分类号:R725.6
引用信息:
[1]底建辉,王婧文,徐锋,等.血清炎症标志物联合肺功能指标对儿童肺炎支原体肺炎病情严重程度的预测价值[J].中国实验诊断学,2025,29(12):1370-1375.
基金信息:
北京市大兴区人民医院科研课题(4202411502)